The short version
8 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Rugby mometasone furoate nasal
mometasone furoate · MOMETASONE FUROATE MONOHYDRATE 50 ug/1 · Spray, Metered · Nasal · Rugby Laboratories
NDC 00536-1381-30 · 1 BOTTLE, SPRAY in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, SPRAY · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Part D plans paid (avg)$117.78per dosage unitgross, before rebates — matched by drug name · 2024
- Federal contracts pay (FSS)$12.84per package of 17GMThe Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs · Jun 1, 2025
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicaid spend (2025)
$18,337
616 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for mometasone furoate (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA215712
- TE code
- —
- Approval date
- Mar 17, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of mometasone furoate (Spray, Metered)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amazon.com Services LLC | MOMETASONE FUROATE MONOHYDRATE 50 ug/1 | Sep 3, 2026 | Sep 3, 2026 |
| Apotex Corp. | MOMETASONE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurohealth LLC | MOMETASONE FUROATE MONOHYDRATE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health 110, LLC. dba Leader | MOMETASONE FUROATE MONOHYDRATE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cvs Woonsocket Prescription Center, Incorporated | MOMETASONE FUROATE MONOHYDRATE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | MOMETASONE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| L. Perrigo Company | MOMETASONE FUROATE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| L. Perrigo Company | MOMETASONE FUROATE MONOHYDRATE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rugby Laboratories | MOMETASONE FUROATE MONOHYDRATE 50 ug/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Rugby mometasone furoate nasal — NDC 00536-1381-30," retrieved September 3, 2026, https://drugdashboards.com/drug/00536138130.
Free to cite with attribution — see how the data is put together.